Skip to main content
Premium Trial:

Request an Annual Quote

Wait a Second

While the creation of a new translational medicine center at NIH, and the dismantling of the National Center for Research Resources, seems to be nearly a certainty, Writedit at Medical Writing, Editing, & Grantsmanship notes that two US senators have voiced their "concern and opposition" to the plan. Senators Daniel Inouye (D-HI) and Mark Begich (D-AK) wrote a letter, posted here by Nature's Great Beyond blog, to Health and Human Services Secretary Kathleen Seblius and NIH Director Francis Collins opposing any changes to where the Institutional Development Award program, currently part of NCRR, is housed. "We find the current placement of the IDeA program within the National Center for Research Resources to be working well. The NCRR staff has worked diligently to familiarize themselves with the research expertise within our states and fostered substantial growth of our research enterprise," the senators write. "A disruption of the placement and expertise at NCRR will only serve to dismantle the laudable work that has been accomplished." Inouye and Begich also are concerned about divorcing the IDeA program from the Research Centers in Minority Institutions. In addition, Inouye chairs the Senate Appropriations Committee, which as ScienceInsider puts it "holds the purse strings for NIH's budget."

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.